Both FOXP1 and p65 expression are adverse risk factors in diffuse large B-cell lymphoma: A retrospective study in China

MLA

Hu, Cheng-Ru, et al. “Both FOXP1 and P65 Expression Are Adverse Risk Factors in Diffuse Large B-Cell Lymphoma: A Retrospective Study in China.” Acta Histochemica, vol. 115, no. 2, Mar. 2013, pp. 137–43. EBSCOhost, https://doi.org/10.1016/j.acthis.2012.06.001.

APA

Hu, C.-R., Wang, J.-H., Wang, R., Sun, Q., & Chen, L.-B. (2013). Both FOXP1 and p65 expression are adverse risk factors in diffuse large B-cell lymphoma: A retrospective study in China. Acta Histochemica, 115(2), 137–143. https://doi.org/10.1016/j.acthis.2012.06.001

Chicago

Hu, Cheng-Ru, Jing-Hua Wang, Rui Wang, Qian Sun, and Long-Bang Chen. 2013. “Both FOXP1 and P65 Expression Are Adverse Risk Factors in Diffuse Large B-Cell Lymphoma: A Retrospective Study in China.” Acta Histochemica 115 (2): 137–43. doi:10.1016/j.acthis.2012.06.001.